Cargando…
Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the oxidativ...
Autores principales: | Ji, Mingyue, Liu, Yun, Zuo, Zhi, Xu, Cheng, Lin, Li, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394079/ https://www.ncbi.nlm.nih.gov/pubmed/35996142 http://dx.doi.org/10.1186/s13062-022-00334-w |
Ejemplares similares
-
Tumstatin (69–88) alleviates heart failure via attenuating oxidative stress in rats with myocardial infarction
por: Zhu, Congfei, et al.
Publicado: (2022) -
Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α(−/−) Mice
por: Kumari, Ritu, et al.
Publicado: (2022) -
Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018) -
Stress-Induced Neuroprotective Effects of Epiregulin and Amphiregulin
por: Zhan, Libin, et al.
Publicado: (2015) -
Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension
por: Florentin, Jonathan, et al.
Publicado: (2022)